We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Deb
Pal
deb.pal@kcl.ac.uk
Sylvine
Lalnunhlimi
sylvine.1.lalnunhlimi@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Episodic and paroxysmal disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Epilepsy is a common neurological disorder affecting 1% of the population. There are over 30 types of epilepsy, some
common, some rare. Most epilepsies arise in childhood and have a genetic cause. Approximately 40% of patients
have the common forms of Genetic Generalised Epilepsy (GGE), and the commonest GGE is “Juvenile Myoclonic
Epilepsy” or JME. The goal of this study is to find the genetic cause for JME. We will do this by comparing the genetic
code in JME patients with that in people who do not have epilepsy. We will use clues from their electroencephalograph
or brainwave test that is used to help diagnose epilepsy.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Genetic epidemiology;
You can take part if:
You may not be able to take part if:
(a) Myoclonus only associated with carbamazepine or lamotrigine therapy (b) EEG showing predominant focal interictal epileptiform discharges or abnormal background (c) Any evidence of progressive or symptomatic myoclonus epilepsy or focal seizures (d) Global learning disability (e) Dysmorphic syndrome (f) Unable to provide informed consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Sylvine
Lalnunhlimi
sylvine.1.lalnunhlimi@kcl.ac.uk
Prof
Deb
Pal
deb.pal@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by King's College London and funded by Canadian Institutes of Health Research .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 34096
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
